{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-047143","form_type":"8-K","ticker":"BLFS","cik":"0000834365","company_name":"BIOLIFE SOLUTIONS INC","filed_at":"2024-11-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:11.130685+00:00","generated_at":"2026-05-30T02:32:30.094531+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"BioLife Solutions Q3 revenue up 30% to $30.6M; raises Cell Processing guidance to $72-73M","bullets":["Q3 revenue $30.6M (+30% YoY); Cell Processing $19.0M (+43% YoY); adjusted EBITDA $6.1M (20% margin).","GAAP net loss from continuing ops $1.7M vs $15.8M YoY; adj. gross margin 54% (up from 44%).","Completed sale of SciSafe biostorage business for $73M cash on Nov 12, 2024.","FY2024 revenue guidance revised to $98-100M; Cell Processing raised to $72-73M (previously $70-71M).","Biostorage guidance cut to $26-27M due to SciSafe divestiture; management expects positive adjusted EBITDA for full year."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-047143","json":"https://secwatch.observer/filing/0001628280-24-047143.json","markdown":"https://secwatch.observer/filing/0001628280-24-047143.md","text":"https://secwatch.observer/filing/0001628280-24-047143.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/834365/000162828024047143/0001628280-24-047143-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/834365/000162828024047143/blfs-20241112.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T02:32:30.094531+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}